Back
Phathom Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
18
PHAT
Phathom Pharmaceuticals
Last Price:
$7.65
Seasonality Move:
-9.47%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight buying pressure.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.85 | Sell |
| 20-day SMA: | 8.41 | Sell |
| 50-day SMA: | 11.91 | Sell |
| 200-day SMA: | 12.08 | Sell |
| 8-day EMA: | 7.84 | Sell |
| 20-day EMA: | 8.66 | Sell |
| 50-day EMA: | 10.86 | Sell |
| 200-day EMA: | 12.06 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.1 | Sell |
| Relative Strength Index (14 RSI): | 31.11 | Sell |
| Chaikin Money Flow: | 55204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.97 - 9.17) | Sell |
| Bollinger Bands (100): | (9.88 - 17.7) | Sell |
Phathom Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 7.50 while PHAT 8-day simple moving average is 7.85, which is a Sell signal.
-
The stock price of PHAT is 7.50 while Phathom Pharmaceuticals 20-day SMA is 8.41, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 11.91 while PHAT share price is 7.50, making it a Sell technically.
-
PHAT stock price is 7.50 and Phathom Pharmaceuticals 200-day simple moving average is 12.08, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
18
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $7.50. The Score for PHAT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
512.8M
Price in USD:
7.50
Share Volume:
401.7K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
6.07
Sell
18
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 7.50 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 7.50 while PHAT 8-day exponential moving average is 7.84, which is a Sell signal.
-
The stock price of PHAT is 7.50 while Phathom Pharmaceuticals 20-day EMA is 8.66, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 10.86 while PHAT share price is 7.50, making it a Sell technically.
-
PHAT stock price is 7.50 and Phathom Pharmaceuticals 200-day simple moving average is 12.06, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $1.13 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -1.1, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 31.11, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (7.97 - 9.17), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.88 - 17.7), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.